does kaiser cover glp 1 drugs A Closer Look: GLP-1 Medications for Weight Loss Prescribing GLP-1s: Evidence, limits, expectations
Description
doi:10.3233/JAD-130491 34
GLP-1 agonists may exert a centrally mediated effect to reduce addictive behavior at least partly via dopamine modulation
The FDA has expressed willingness to provide regulatory flexibility toward compounders that keep filling requests that were made prior to the shortage ending
For more information: Allie Seminer , MSc, and Alfredi Mulihano , undergraduate students in the School of Medicine at the University of Galway in Ireland, can be reached at [email protected]
Ann Pharmacother
If someone is experiencing side effects, it is important to have them reach out to a health care provider
